Tag
#SF
-
2026
-
Whitehawk Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum
-
IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day
-
MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum
-
Cloudbreak Pharma to Present at the Stifel 2026 Virtual Ophthalmology Forum
-
AN2 Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum
-
Stifel Launches Project Finance Offering to Expand Energy and Deep Tech Capabilities
-
SF – 10-Q
-
Stifel Declares Quarterly Common Stock Cash Dividend and Declares Preferred Stock Cash Dividend
-
SF – DEF 14A
-
SF – DEFA14A
-
Stifel Reports First Quarter 2026 Results
-
SF – 8-K
-
Stifel Financial Schedules First Quarter Financial Results Conference Call
-
Stifel Strengthens Equities Platform With Senior Hire
-
Stifel Reports February 2026 Operating Data
-
SF – 8-K
-
Stifel Reports February 2026 Operating Data
-
KBW Announces Index Rebalancing for First-Quarter 2026
-
Acadia Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
-
Stifel Welcomes Veteran Healthcare Bankers Ajay Pathak and Bill Reisner as Managing Directors in Public Finance
-
Stifel Welcomes Veteran Healthcare Bankers Ajay Pathak and Bill Reisner as Managing Directors in Public Finance
-
Minerva Neurosciences to Participate in The Stifel 2026 Virtual CNS Forum
-
Compass Pathways to Present at Stifel 2026 Virtual CNS Forum on March 18, 2026
-
Neurogene to Participate in Stifel 2026 Virtual CNS Forum
-
Alkermes to Present at the Stifel 2026 Virtual CNS Forum